MTX:XETRMTU Aero Engines AG Analysis
Data as of 2026-03-10 - not real-time
$67.75
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Minerals Technologies (MTX) is trading well below its discounted cash‑flow estimate and analyst price targets, offering roughly a 28% upside. The 20‑day SMA sits above the 50‑day and 200‑day averages, confirming a bullish medium‑term trend, while the RSI hovers near 40, suggesting room for further price appreciation. However, the MACD remains bearish and the stock is trading close to its technical support at $64.86, indicating short‑term downside pressure. The company’s forward PE of under 10, a modest dividend yield of 0.71% backed by positive free cash flow, and a recent upgrade to “Buy” reinforce the valuation case. Upcoming Q4 2025 earnings on Jan 29 2026 could provide a catalyst, especially if the reported revenue growth of 0.3% translates into improved margins and profitability.
Overall, MTX combines a compelling value proposition with a resilient dividend history and a diversified global footprint, but investors should remain mindful of the high 30‑day volatility, a recent MACD bearish signal, and the need for a turnaround in net earnings. The blend of upside potential, solid cash generation, and ongoing dividend payments makes the stock attractive for medium‑ to long‑term investors, while short‑term positioning may warrant caution until the earnings release clarifies the earnings trajectory.
Overall, MTX combines a compelling value proposition with a resilient dividend history and a diversified global footprint, but investors should remain mindful of the high 30‑day volatility, a recent MACD bearish signal, and the need for a turnaround in net earnings. The blend of upside potential, solid cash generation, and ongoing dividend payments makes the stock attractive for medium‑ to long‑term investors, while short‑term positioning may warrant caution until the earnings release clarifies the earnings trajectory.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at $64.86
- Bearish MACD histogram indicating short‑term momentum weakness
- Upcoming earnings release could confirm trend direction
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 28% upside to DCF fair value and analyst price targets
- Forward PE below 10 suggesting strong value appeal
- Dividend sustainability supported by positive free cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Discounted valuation relative to DCF and long‑term growth prospects
- 34‑year uninterrupted dividend track record
- Diversified global operations reducing single‑market exposure
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin-0.89%
P/E Ratio9.7
ROE-0.79%
ROA5.23%
Debt/Equity57.85
P/B Ratio1.2
Op. Cash Flow$193.7M
Free Cash Flow$269.3M
Technical Analysis
TrendBullish
RSI40.5
Support$64.86
Resistance$75.30
MA 20$71.10
MA 50$68.24
MA 200$61.65
MACDBearish
VolumeStable
Fear & Greed Index77.48
Valuation
Fair Value$99.33
Target Price$87.25
Upside/Downside28.78%
GradeUndervalued
TypeBlend
Dividend Yield0.71%
Risk Assessment
Beta0.91
Volatility25.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.